Received: 30 July 2020
Accepted: 15 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: Study protocol was approved through the McMaster Research Ethics Board.
: Not applicable.
: AG, MT, JP declare that they have no competing interests. HK has been on Speakers’ Bureau and/or Advisory Boards for AstraZeneca, Aralez, CSL Behring, GSK, Kaleo, Merck, Mylan, Novartis, Pediapharm, Sanofi, Shire. Dr. Kim has received research funding from Astrazeneca, Shire, Novartis.